Ladenburg Thalmann analyst John Massocca maintains Essential Props Realty (NYSE:EPRT) with a Buy and lowers the price target from $28 to $27.
Equillium’s Itolizumab Reduces Urine Protein In Lupus Patients
Equillium Inc (NASDAQ:EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic…